Literature DB >> 15471880

Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability.

Lily Y Moy1, Li-Huei Tsai.   

Abstract

Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis, and its activity is regulated by phosphorylation in the N-terminal regulatory domain. The proline-directed serine/threonine kinase cyclin-dependent kinase 5 (cdk5) plays an important role in diverse neuronal processes. In the present study, we identify TH as a novel substrate of cdk5. We show that cdk5 phosphorylates TH at serine 31 and that this phosphorylation is associated with an increase in total TH activity. In transgenic mice with increased cdk5 activity, the immunoreactivity for phosphorylated TH at Ser-31 is enhanced in neurons of the substantia nigra, a brain region enriched with TH-positive neurons. In addition, we demonstrate that co-expression of cdk5 and its regulatory activator p35 with TH increases the stability of TH. Consistent with these findings, TH protein levels are reduced in cdk5 knock-out mice. Importantly, the TH activity and protein turnover of the phosphorylation-defective mutant TH S31A was not altered by cdk5 activity. Taken together, these data suggest that cdk5 phosphorylation of TH is an important regulator of TH activity through stabilization of TH protein levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471880     DOI: 10.1074/jbc.M406636200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

Authors:  Ana Jorge-Finnigan; Rune Kleppe; Kunwar Jung-Kc; Ming Ying; Michael Marie; Ivan Rios-Mondragon; Michael F Salvatore; Jaakko Saraste; Aurora Martinez
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  Ciliary neurotrophic factor stimulates tyrosine hydroxylase activity.

Authors:  Xiao Shi; William R Woodward; Beth A Habecker
Journal:  J Neurochem       Date:  2012-04-12       Impact factor: 5.372

Review 3.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

4.  Ca2+/Calmodulin-dependent protein kinase kinase beta is regulated by multisite phosphorylation.

Authors:  Michelle F Green; John W Scott; Rohan Steel; Jonathan S Oakhill; Bruce E Kemp; Anthony R Means
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

5.  Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.

Authors:  Amit Saraf; Elizabeth A Oberg; Stefan Strack
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

6.  Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Authors:  Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

7.  Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90.

Authors:  Dao-Yao He; Dorit Ron
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

8.  A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury.

Authors:  Andrew M Slupe; Ronald A Merrill; Kyle H Flippo; Mark A Lobas; Jon C D Houtman; Stefan Strack
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

9.  Loss of Cdk5 function in the nucleus accumbens decreases wheel running and may mediate age-related declines in voluntary physical activity.

Authors:  Gregory N Ruegsegger; Ryan G Toedebusch; Thomas E Childs; Kolter B Grigsby; Frank W Booth
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

10.  Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.

Authors:  David A Price; Alexander Sorkin; Nancy R Zahniser
Journal:  Mol Pharmacol       Date:  2009-07-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.